Should you add newly listed Warpaint London plc to your investing arsenal?

Paul Summers looks at the investment case for cosmetics firm and new-share-on-the-block, Warpaint London plc (LON:W7L).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Warpaint

Image: Warpaint: Fair use

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s always worth keeping a watch on companies that have recently come to the market. So long as the investment case is solid, those who buy shares early on can often enjoy quick capital gains. 

One recent example is colour cosmetics business Warpaint London (LSE: W7L). Since arriving on AIM back in November, shares in the Buckinghamshire-based company have jumped from its IPO price of 97p to 165p. A 70% return in just over three months? Now that’s a company I want to learn more about.

Looking good

Warpaint London focuses on offering consumers in the 16-30 age range “high quality cosmetics at affordable prices“. With more than 500 items, its flagship W7 brand is sold to high street retailers and independent beauty shops in over 40 countries. In addition to this, Warpaint also operates a close-out division which buys excess stock of branded cosmetics such as Max Factor before selling them on to discounters.

Although new to the stock market, a quick glance at its financial history suggests this could be a stock to buy and hold for the medium-to-long term. Annual returns on capital over the three-year period from 2013-15 were all around the 50% mark. Take into account the company’s net cash position and the fact that sales of lipstick and eyeliner will continue regardless of the macroeconomic picture and things start looking pretty attractive.

Another point worth mentioning is Warpaint’s relatively low free float. At the time of writing, only 36% of the company’s 65m shares are available to investors. The remainder are held by the company’s board, with joint CEOs Samuel Banzini and Eoin Macleod owning a combined 63% stake. In addition to guaranteeing that both will be highly motivated in pushing the business forward, you can also be sure that this limited availability will mean that any positive news (such as the introduction of a dividend) could lead to a significant jump in the share price.

Shares in Warpaint trade on a not-unreasonable 17 times earnings for 2017. What’s more interesting however, is that the price-to-earnings growth (PEG) ratio is only 0.7. As a general rule of thumb, anything less than one on this metric is indicative of a company offering excellent value for money given management’s plans for expansion.

Things to be wary of? Even those with meagre knowledge of the products will recognise the highly competitive nature of the cosmetics market. Warpaint’s dependence on two highly-motivated CEOs to drive the company forward could also backfire if one or both ever decide to leave. 

Bog standard profits

If adding Warpaint to your portfolio doesn’t appeal but you remain interested in small companies selling products that people buy on a regular basis, shares in Accrol Group (LSE: ACRL) might be a viable alternative.

Based in Blackburn, the £135m cap manufactures toilet rolls, kitchen rolls and facial wipes. It’s hardly exciting stuff but then some of the best investments never are. Since coming to the market last June, shares in the owner of brands such as Sofcell and Thirsty Bubbles have put in a very encouraging performance, rising 29% to 142p.

Trading on 11 times earnings for this year, reducing to 10 in 2018 so long as earnings growth estimates of 10% are hit, stock in Accrol still doesn’t look expensive. Like Warpaint, Accrol also has a low PEG ratio of just one for 2017. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Here’s how I’m using a £20k ISA to target £11k+ in income 30 years from now

Is it realistic to put £20k in an ISA now and earn over half that amount every year in passive…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

If I could only keep 5 UK stocks from my portfolio I’d save these

Harvey Jones is running through his portfolio of top UK stocks to see which ones he couldn't bear to do…

Read more »

Midnight is celebrated along the River Thames in London with a spectacular and colourful firework display.
Investing Articles

I’m aiming for a million buying unexciting shares!

By investing regularly in long-established, proven and even rather dull businesses, this writer plans to aim for a million. Here's…

Read more »

Investing Articles

3 things to consider before you start investing

Our writer draws on his stock market experience to consider a few vital lessons he would use to start investing…

Read more »

Investing Articles

Will this lesser-known £28bn growth stock be joining the FTSE 100 soon?

As the powers that be plan a reorganisation of Footsie listing rules, this massive under-the-radar growth stock could find its…

Read more »

Investing Articles

Fools wouldn’t touch these 5 FTSE 350 flops with a bargepole – how come I own 3 of them?

Harvey Jones took a chance on three struggling FTSE 350 stocks in the hope that they'd stage a dramatic recovery.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

How I’m trying to make a million from passive income

Invest as much as possible, regularly, and use the passive income to plough back into more shares. Here's how millionaires…

Read more »

Investing Articles

I’d buy 30,434 shares of this UK dividend stock to target £175 a month in passive income

A top insider has spent over £1m buying this 9%-yielding passive income share over the last year. Roland Head explains…

Read more »